288 related articles for article (PubMed ID: 30780007)
1. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K
Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
[TBL] [Abstract][Full Text] [Related]
2. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study.
Mitaka C; Kawagoe I; Satoh D; Hayashida M
Clin Appl Thromb Hemost; 2021; 27():10760296211050356. PubMed ID: 34859680
[TBL] [Abstract][Full Text] [Related]
3. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
[TBL] [Abstract][Full Text] [Related]
4. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
Kawano N; Tasaki A; Kuriyama T; Tahara Y; Yoshida S; Ono N; Himeji D; Yamashita K; Shibata Y; Goto T; Inoue T; Yokota-Ikeda N; Uezono S; Yuge A; Nishiguchi T; Kinjo T; Ogura Y; Beppu K; Ueda Y; Kinoshita M; Moritake H; Shimoda K; Ochiai H; Ueda A
Intern Med; 2014; 53(3):205-13. PubMed ID: 24492688
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
[TBL] [Abstract][Full Text] [Related]
7. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M
Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N; Yoshida S; Ono N; Himeji D; Nagahiro Y; Sayaka Kawano ; Yamashita K; Ikeda N; Uezono S; Ochiai H; Kawano F; Kikuchi I; Ishikawa F; Shimoda K; Ueda A; Akashi K
J Clin Exp Hematop; 2011; 51(2):101-7. PubMed ID: 22104308
[TBL] [Abstract][Full Text] [Related]
10. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
11. [Clinical Efficacy of Recombinant Human Thrombomodulin for Surgical Patients with Disseminated Intravascular Coagulation Associated with Oncologic Emergency].
Ikuta L; Nakajima T; Fujikawa M; Nomura K; Matsuki G; Ichise N; Kasai M; Okamoto R; Ikuta S; Nakamoto Y; Aihara T; Yanagi H; Yamanaka N
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1408-1410. PubMed ID: 36733084
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study).
Ogura T; Eguchi T; Nakahara K; Kanno Y; Omoto S; Itonaga M; Kuroda T; Hakoda A; Ikeoka S; Takagi M; Okada A; Sato J; Morita R; Michikawa Y; Ito K; Koshita S; Takenaka M; Kitano M; Koizumi M; Higuchi K
J Hepatobiliary Pancreat Sci; 2023 Feb; 30(2):221-228. PubMed ID: 34021720
[TBL] [Abstract][Full Text] [Related]
13. Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: a single institution experience.
Yagasaki H; Kato M; Shimozawa K; Hirai M; Nishikawa E; Okuma H; Ishii W; Imai Y; Matsumura M; Yonezawa R; Yoshikawa K; Shichino H; Chin M; Mugishima H
Thromb Res; 2012 Dec; 130(6):e289-93. PubMed ID: 23123162
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study.
Hirata N; Ngo DT; Phan PH; Ainai A; Phung TTB; Ta TA; Takasaki J; Kawachi S; Nunoi H; Nakajima N; Dien TM
J Anesth; 2021 Oct; 35(5):638-645. PubMed ID: 34259911
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Thrombomodulin in Disseminated Intravascular Coagulation Associated with Stage IV Solid Tumors: A Nationwide Observational Study in Japan.
Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
Thromb Haemost; 2021 Jan; 121(1):36-45. PubMed ID: 32906154
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
Machioka K; Shigehara K; Kadomoto S; Iwamoto H; Miyagi T; Nakashima T; Namiki M
Hinyokika Kiyo; 2015 Jan; 61(1):1-6. PubMed ID: 25656012
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N
Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090
[TBL] [Abstract][Full Text] [Related]
18. [A case of esophageal cancer with septic disseminated intravascular coagulation treated with recombinant human soluble thrombomodulin during chemoradiation therapy].
Sasaki K; Okumura H; Uchikado Y; Minami K; Ijichi T; Owaki T; Ishigami S; Natsugoe S
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1213-5. PubMed ID: 24047782
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
[TBL] [Abstract][Full Text] [Related]
20. Factors Determining the Efficacy of Recombinant Human Thrombomodulin in the Treatment of Sepsis-Induced Disseminated Intravascular Coagulation.
Kotake K; Hongo T; Tahira A; Niimi N; Haisa I; Kawakami Y
Biol Pharm Bull; 2021 May; 44(5):605-610. PubMed ID: 33612566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
